Exercise of stock options awarded under the issuer's incentive compensation plan. | Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date.
CAHILL JOHN T
Director·Direct
Exercise · Acquire
Common Stock
Shares+4.17K
Price$71.56
Total Value$298.4K
Shares Owned After32.54K
Transaction DateAug 6, 2026
Footnotes ▸
Exercise of stock options awarded under the issuer's incentive compensation plan.
CAHILL JOHN T
Director·Direct
Sell · Dispose
Common Stock
Shares-4.17K
Price$93.37
Total Value$389.4K
Shares Owned After28.37K
Transaction DateAug 6, 2026
Footnotes ▸
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
CAHILL JOHN T
Director·Indirect · By Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After36.36K
Post-Transaction Holdings
CAHILL JOHN T
Security
Shares
Change
Common Stock
68.90K
-
Stock Option (Right to Buy)
0
-4.17K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-06
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: COLGATE PALMOLIVE CO (CL)
CIK: 0000021665
--- Reporting Owner ---
Name: CAHILL JOHN T
CIK: 0001197000
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-08-06 | Code: M (Exercise of derivative)
Shares: +4,170 | Price: $71.56
Total Value: $298,405.20
Shares Owned After: 32,543 | Ownership: D (Direct)
Footnotes:
[F1] Exercise of stock options awarded under the issuer's incentive compensation plan.
[Transaction #2]
Security: Common Stock
Date: 2026-08-06 | Code: S (Open market sale)
Shares: -4,170 | Price: $93.37
Total Value: $389,357.90
Shares Owned After: 28,373 | Ownership: D (Direct)
Footnotes:
[F2] Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
[F3] Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
--- Derivative Transactions ---
[Transaction #1]
Security: Stock Option (Right to Buy)
Date: 2026-08-06 | Code: M (Exercise of derivative)
Shares: -4,170 | Price: $0.00
Exercisable: N/A | Expires: 2027-05-13
Shares Owned After: 0 | Ownership: D (Direct)
Footnotes:
[F1] Exercise of stock options awarded under the issuer's incentive compensation plan.
[F4] Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date.
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
--- Footnotes (Complete Index) ---
F1: Exercise of stock options awarded under the issuer's incentive compensation plan.
F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date.
--- Signature ---
/s/ /s/ Kristine Hutchinson, Attorney-in-Fact (2026-08-07)